• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

McKesson’s Paula Bickley on Maintaining Patient Centeredness


Featured speaker at the 4th Annual PBMI Specialty Rx Forum on October 16 discusses theme of the meeting.

Paula Bickley, vice president of market access for biologics at McKesson and one of the featured speakers at tomorrow’s 4th Annual PBMI Specialty Rx Forum, spoke with Managed Healthcare Executive® Senior Editor Peter Wehrwein.

Bickley and Wehrwein talked about the theme of the meeting, maintaining patient-centeredness, the advantages that approach has for takeholders, the savings it would mean, and the challenges it poses.

The Pharmacy Benefit Management Institute® is a provider of research and education about drug cost management. 

There is still time to register for the meeting. Click here to register.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.